On September 20, Hailir Pesticides and Chemicals Group (603639.SH) stated on the investor interaction platform that the original drug of oxazolidinone, as well as 2-chloroacrylonitrile and para-chlorophenylglycine projects, have entered the trial production stage, which will bring good assistance to the company's development.
海利尔(603639.SH)：唑虫酰胺原药以及2-氯丙烯腈、对氯苯甘氨酸项目已进入试生产阶段
Hailir (603639.SH): The original drug of oxazolidinone insecticides, as well as the projects of 2-chloroacrylonitrile and para-chlorophenylglycine, have entered the trial production stage.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated